A Phase 2, Multi-Center, Double-Blind, Placebo-Controlled, Flexible Dose Study To Assess The Efficacy and Safety Of Oral UK-390,957 In Men With Premature Ejaculation
Phase of Trial: Phase II/III
Latest Information Update: 06 Nov 2012
At a glance
- Drugs UK 390957 (Primary)
- Indications Premature ejaculation
- Focus Registrational; Therapeutic Use
- 06 Nov 2012 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.
- 28 Aug 2006 Status change
- 05 Nov 2005 New trial record.